HomeTrialNCT06333704
🔬NCT06333704RECRUITING

Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.

Study Summary

The main objective of the surveillance is to evaluate the incidence of the adverse events (AEs), and other safety related information in South-Korean population.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment4206 participants
Primary Completion
Lead SponsorModernaTX, Inc.
Data Retrieved2026-04-11 02:55:38.209185+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.